AP2906A - A composition and method for creation of ABME and uses thereof - Google Patents

A composition and method for creation of ABME and uses thereof

Info

Publication number
AP2906A
AP2906A AP2007004164A AP2007004164A AP2906A AP 2906 A AP2906 A AP 2906A AP 2007004164 A AP2007004164 A AP 2007004164A AP 2007004164 A AP2007004164 A AP 2007004164A AP 2906 A AP2906 A AP 2906A
Authority
AP
ARIPO
Prior art keywords
abme
creation
composition
Prior art date
Application number
AP2007004164A
Other languages
English (en)
Other versions
AP2007004164A0 (en
Inventor
Vaijanti Prakesh Kale
Lakshmi Charan Padhy
Original Assignee
Nat Ct Cell Sciences
Tata Inst Of Fundamental Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Ct Cell Sciences, Tata Inst Of Fundamental Res filed Critical Nat Ct Cell Sciences
Publication of AP2007004164A0 publication Critical patent/AP2007004164A0/xx
Application granted granted Critical
Publication of AP2906A publication Critical patent/AP2906A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0669—Bone marrow stromal cells; Whole bone marrow
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/14—Calcium; Ca chelators; Calcitonin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/585—Integrins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1394—Bone marrow stromal cells; whole marrow
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/04—Screening or testing on artificial tissues

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
AP2007004164A 2005-03-01 2005-07-22 A composition and method for creation of ABME and uses thereof AP2906A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN230MU2005 2005-03-01
PCT/IB2005/002249 WO2006092650A2 (en) 2005-03-01 2005-07-22 A composition for creating an artificial bone -marrow like environment and use thereof

Publications (2)

Publication Number Publication Date
AP2007004164A0 AP2007004164A0 (en) 2007-10-31
AP2906A true AP2906A (en) 2014-05-31

Family

ID=36613442

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007004164A AP2906A (en) 2005-03-01 2005-07-22 A composition and method for creation of ABME and uses thereof

Country Status (13)

Country Link
US (1) US20080241870A1 (he)
EP (1) EP1856245A2 (he)
JP (1) JP5367988B2 (he)
KR (1) KR101318965B1 (he)
CN (1) CN101137747B (he)
AP (1) AP2906A (he)
AU (1) AU2005328537B2 (he)
BR (1) BRPI0518543A2 (he)
CA (1) CA2598936A1 (he)
IL (1) IL185516A (he)
MX (1) MX2007010741A (he)
NZ (1) NZ560813A (he)
WO (1) WO2006092650A2 (he)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014002347B1 (pt) * 2011-08-05 2021-09-21 Inserm - Institut National De La Santé Et De La Recherche Médicale Método in vitro para determinar um risco de desenvolvimento de fibrose hepática ou cirrose
EP3252144A4 (en) * 2015-01-28 2018-08-08 Public University Corporation Yokohama City University Method for preparing bone marrow cell aggregate
CN105039334B (zh) * 2015-08-26 2017-12-29 山西省农业科学院畜牧兽医研究所 一种鉴别生长性能优异的晋南牛的igf2基因分子标记及其应用
US10815125B2 (en) * 2018-01-05 2020-10-27 Wisconsin Alumni Research Foundation Removable non-conjugated polymers for dispersing carbon nanotubes
CN108359637B (zh) * 2018-02-14 2021-09-28 浙江生创精准医疗科技有限公司 一种宫血干细胞快速扩增的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733542A (en) * 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8707673A (pt) * 1986-04-18 1989-08-15 Marrow Tech Inc Processo para reproduzir medula ossea
US6281408B1 (en) * 1998-02-20 2001-08-28 Thomas Jefferson University Efficient method for production of compound transgenic animals
US6541249B2 (en) * 1999-12-22 2003-04-01 Human Genome Sciences, Inc. Immortalized human stromal cell lines
US6824973B2 (en) * 2000-02-03 2004-11-30 Kirin Beer Kabushiki Kaisha Method of promoting stem cell proliferation or survival by contacting a cell with a stem cell factor-like polypeptide
WO2002022788A1 (fr) * 2000-09-12 2002-03-21 Yukio Kato Procede de mise en culture de cellules souches mesenchymateuses
US20040235160A1 (en) * 2001-08-07 2004-11-25 Mitsuo Nishikawa Process for preparing hematopoietic stem cells
WO2003042376A1 (en) * 2001-11-15 2003-05-22 Photothera, Inc. Methods for preparing artificial cartilage

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733542A (en) * 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
ANEPUCCI R A ET AL: "COMPARISON OF GENE EXPRESSION OF MESENCHYMAL STEM CELLS FROM THE UMBILICAL CORD AND FROM THE BONE MARROW" BLOOD, W.B.SAUNDERS COMPANY, ORLANDO, FL, US, vol. 102, no. 11, 16 November 2003 (2003-11-16), page 178B,ABSTRNO4427 *
DE LA FUENTE JOSU ET AL: "Circulating human fetal mesenchymal stem cells support LTC-IC and express a cytokine profile to maintain quiescence of co-circulating hemopoietic stem cells." BLOOD, vol. 104, no. 11, Part 1, November 2004 (2004-11), pages 640A-641A, XP002470467 & 46TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; SAN DIEGO, CA, USA; DECEMBER 04 -07, 2004 *
DEANS ROBERT J ET AL: "Mesenchymal stem cells: Biology and potential clinical uses" EXPERIMENTAL HEMATOLOGY, NEW YORK, NY, US, vol. 28, no. 8, August 2000 (2000-08), pages 875-884 *
KOC OMER N ET AL: "Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy" JOURNAL OF CLINICAL ONCOLOGY, vol. 18, no. 2, January 2000 (2000-01), pages 307-316 *
MAJUMDAR M K ET AL: "PHENOTYPIC AND FUNCTIONAL COMPARISON OF CULTURES OF MARROW-DERIVED MESENCHYMAL STEM CELLS (MSCS) AND STROMAL CELLS" JOURNAL OF CELLULAR PHYSIOLOGY, LISS, NEW YORK, NY, US, vol. 176, no. 1, 1998, pages 57-66 *
MCNIECE I ET AL: "Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells." CYTOTHERAPY. 2004, vol. 6, no. 4, 2004, pages 311-317 *
PITTENGER M F ET AL: "MULTILINEAGE POTENTIAL OF ADULT HUMAN MESENCHYMAL STEM CELLS" SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 284, no. 5411, 2 April 1999 (1999-04-02), pages 143-147 *
SHPALL E J ET AL: "Transplantation of ex vivo expanded cord blood" BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, KLUGE CARDEN JENNINGS PUBLISHING, CHARLOTTESVILLE, VA, US, vol. 10, no. 10, October 2004 (2004-10), page 738 *
WANG JIN-FU ET AL: "Mesenchymal stem/progenitor cells in human umbilical cord blood as support for ex vivo expansion of CD34+ hematopoietic stem cells and for chondrogenic differentiation" HAEMATOLOGICA, vol. 89, no. 7, July 2004 (2004-07), pages 837-844 *
ZHANG YI ET AL: "Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34+ cells" EXPERIMENTAL HEMATOLOGY (NEW YORK), vol. 32, no. 7, July 2004 (2004-07), pages 657-664 *

Also Published As

Publication number Publication date
IL185516A0 (en) 2008-01-06
KR101318965B1 (ko) 2013-10-17
WO2006092650A3 (en) 2007-02-22
NZ560813A (en) 2010-04-30
IL185516A (he) 2015-08-31
US20080241870A1 (en) 2008-10-02
WO2006092650A2 (en) 2006-09-08
CN101137747A (zh) 2008-03-05
EP1856245A2 (en) 2007-11-21
AU2005328537A1 (en) 2006-09-08
MX2007010741A (es) 2008-03-07
JP2008531166A (ja) 2008-08-14
CN101137747B (zh) 2013-10-09
AP2007004164A0 (en) 2007-10-31
KR20080005184A (ko) 2008-01-10
BRPI0518543A2 (pt) 2008-11-25
AU2005328537B2 (en) 2012-02-09
JP5367988B2 (ja) 2013-12-11
CA2598936A1 (en) 2006-09-08

Similar Documents

Publication Publication Date Title
PL1856374T3 (pl) Kompozycja i sposób wytwarzania środka do podsadzki
ZA200803273B (en) Aerosol composition and method
GB0525314D0 (en) Method and composition
EP1915888A4 (en) METHOD AND COMPOSITION FOR THE ADHESION OF MATERIALS BETWEEN THEM
EP1897896A4 (en) CURABLE COMPOSITION AND SEALING METHOD
PL2054128T3 (pl) Kompozycja materiałów i sposób jej wytwarzania
GB0505568D0 (en) Method of manufacture and associated component
TWI365899B (en) Adhesive composition and method
GB0611459D0 (en) Marking composition and method
ZA200605722B (en) Composition and method
GB0524927D0 (en) Compositions and method
ZA200802969B (en) Composition and method
PL2132251T3 (pl) Kompozycja i sposób
AP2906A (en) A composition and method for creation of ABME and uses thereof
GB0620930D0 (en) Composition and method for use thereof
IL192564A0 (en) Composition and method of use thereof
GB0520930D0 (en) Composition and method of use
GB0625208D0 (en) Composition and method
GB0522655D0 (en) Composition and method
TWI350296B (en) Modified substrate and method for producing modified substrate
GB0511235D0 (en) Compositions and method
GB0600261D0 (en) Composition and method
GB0604315D0 (en) Composition and method
EP1927349A4 (en) COMPOSITION FOR EXTENDING LIFE AND METHOD FOR EXTENDING LIFE
GB0607488D0 (en) Composition and process